NOVEMBER SALE - 20% OFF Everything!Shop Now
MT2 Peptide (Melanotan II) - 10mg / Vial
99.715% HPLC purityLot-tested · COA below

MT2 Peptide (Melanotan II)

$35.00each · 10mg / Vial

5.0· 3 reviewsout of 5In stock

MT2 peptide (Melanotan II) 10 mg vial for laboratory research. 99.7% purity by UHPLC-MS, endotoxin tested, public COA. Ships within 24 hours from the US.

Regular price $44.00Sale price $35.00You save $9.00 (20%)
1

Bundle & Save

Need more?

Select and SubscribeSave 20%
Order within 20h 39m to ship Mon, Nov 23Cutoff 5:00 PM PST · ships next business day
U.S. delivery availableFree shipping on orders over $150.00
Reship policyWrong item sent? We reship it free. Transit issues reviewed case by case.

Secure checkout · Visa · Mastercard · American Express · Discover · PayPal · Venmo · Apple Pay

Test results · tested sample

99.715%

Reported purity · Tested by Janoshik

Tested
Jun 19, 2026
Labeled
10mg / Vial
Lab
Janoshik
View certificate (PDF) →

Product details

Melanotan II (MT2), in brief. Melanotan II is a small, ring-shaped lab-made analog of alpha-melanocyte-stimulating hormone (alpha-MSH), the natural hormone that signals pigment cells to darken and feeding circuits in the brain to stand down. It was designed in the late 1980s to last longer and act more potently than the natural hormone; in an isolated lizard skin assay it was about 90 times as potent as alpha-MSH [1]. It does not pick one target. It switches on four of the five melanocortin receptors, which is why one molecule darkens pigment cells, cuts food intake in rodents and triggers erectile responses in rats [3,4,8]. In obese rats it reduced body weight about four times as much as saline over two weeks [5]. Melanotan II itself is not FDA-approved. NextGenPeps supplies Melanotan II (MT2) as a 10 mg lyophilized research material for laboratory use only.

What is in each Melanotan II vial

  • Strength. 10 mg of lyophilized powder in a sealed vial.

  • Appearance. White lyophilized powder.

  • Identity and purity. Identity and purity by UHPLC with mass spectrometry, at 99.715% on the current lot (June 19, 2026), tested by independent labs.

  • Endotoxin. Under 1 EU per vial on the current lot.

  • Certificate of analysis. Every lot is tested by independent labs and the certificate of analysis is published in the NextGenPeps COA library.

  • Fulfilment. Ships within 24 hours from the United States, with free US shipping on orders over $150.

What Melanotan II is

Melanotan II is a seven-residue cyclic analog of alpha-MSH, with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 and the molecular formula C50H69N15O9, about 1024.2 g/mol (CAS 121062-08-6). It was made by trimming alpha-MSH to its active core, swapping in norleucine and D-phenylalanine, and closing the chain into a ring with a lactam bridge, changes that made it resistant to enzymes and prolonged its action in skin assays [1]. It binds MC1R most tightly, followed by MC4R and MC3R, then MC5R, and reached full cAMP output at each receptor in the same assays [3]. Because it activates several melanocortin receptors at once, it is used as a broad reference agonist for the melanocortin system rather than as a probe for a single receptor [3].

MT2 vs MT1 and PT-141

Melanotan I (MT1, afamelanotide) is a linear 13-residue analog of alpha-MSH, studied mainly for pigmentation [2]. Melanotan II is a shorter, cyclic 7-residue analog with tight binding at MC1R, MC3R, MC4R and MC5R, which is why its animal effects reach beyond pigment into feeding and erectile responses [1,3]. As afamelanotide, Melanotan I is FDA-approved as an implant for erythropoietic protoporphyria; Melanotan II is not approved [10]. A close relative, bremelanotide (PT-141), has the same ring and sequence as MT2 except for a free acid at the C-terminus in place of MT2's amide, and is an approved drug; that approval does not extend to Melanotan II [9]. The full comparison of what Melanotan I and Melanotan II did in animal studies is in Melanotan 1 vs 2: What the Animal Studies Actually Showed.

What MT2 is used to study

  • Melanogenesis. MC1R signalling and melanin production in melanocyte cultures and animal skin, the assay in which MT-II was first characterised [1].

  • Feeding and obesity models. The central melanocortin pathway downstream of leptin, including diet-induced and genetic obesity models in rodents [4,5,6].

  • Tachyphylaxis and receptor regulation. Why the appetite effect fades within days while fat loss continues, and how MC4R expression changes [6,7].

  • Erectile and spinal circuits. Brain and spinal melanocortin pathways controlling erection in rats [8].

  • Ligand design. MT-II is the benchmark agonist in binding and cAMP assays for new selective agonists and antagonists [3].

Handling and storage

  • Lyophilized: store the sealed vial at 2 to 8 °C, or −20 °C for longer holding, protected from light and moisture.

  • Reconstituted: hold at 2 to 8 °C, protected from light.

  • Reconstitute with sterile or bacteriostatic water.

  • Avoid repeated freeze-thaw cycles. The tryptophan residue is sensitive to light and oxidation.

Is Melanotan 2 FDA approved?

Melanotan II has never been approved as a drug in the United States. This material is supplied for research use only and is not a drug, supplement, cosmetic or diagnostic. In September 2007 the FDA called Melanotan II "an unapproved product" [11]. In April 2026 the FDA said it would remove Melanotan II from Category 2 of its list of bulk substances that raise significant safety concerns for compounding, and asked its Pharmacy Compounding Advisory Committee to review it before the end of February 2027. Removal from Category 2 does not by itself make a substance eligible for compounding, and that review does not make it an approved drug [12]. Approval of the related peptides bremelanotide (Vyleesi) and afamelanotide (Scenesse) does not extend to Melanotan II [9,10].


Research Use Only. The statements made within this website have not been evaluated by the US Food and Drug Administration. These materials are not intended to diagnose, treat, cure or prevent any disease and are not intended for human or veterinary use. Studies described on this page are reported for scientific context and are not guidance of any kind.

Published research

Compound information

Molecular class
Cyclic heptapeptide analog of alpha-MSH; non-selective melanocortin receptor agonist
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 (lactam bridge Asp5 to Lys10)
Molecular formula
C₅₀H₆₉N₁₅O₉
Molecular weight
~1024.2 g/mol
CAS number
121062-08-6
Receptors
MC1R, MC3R, MC4R, MC5R (reported binding IC50 about 0.2, 1.25, 1.07 and 7.47 nM)
Strength
10 mg per vial
Physical form
White lyophilized powder, sealed vial
Purity
99.715% by UHPLC-MS (current lot, June 19, 2026)
Endotoxin
Under 1 EU per vial (current lot)
Regulatory status
Not FDA-approved; research use only

Storage & stability

  • Lyophilized powder
  • Store cold, protected from light and moisture
  • Avoid repeated freeze-thaw cycles after reconstitution
Lyophilized
2 to 8 °C, or −20 °C for longer holding, in the sealed vial
Reconstituted
2 to 8 °C, protected from light
Reconstitute with
Sterile or bacteriostatic water
Identity check
Mass spectrometry distinguishes MT-II from bremelanotide (about 1 Da apart)

Cited literature

  1. 01
    Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics

    Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ · J Med Chem 1989 · PubMed · DOI

    The design paper for the cyclic lactam series that includes MT-II; the 23-membered ring analogs were up to about 100 times as potent as alpha-MSH in lizard skin, with prolonged activity. Frog and lizard skin bioassays only, not mammalian receptors.

  2. 02
    Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization

    Hadley ME, Dorr RT · Peptides 2006 · PubMed · DOI

    History of melanotan I (linear) and melanotan II (cyclic), their early clinical studies and the move to PT-141. A narrative review written by the compounds' developers.

  3. 03
    Approaches to the rational design of selective melanocortin receptor antagonists

    Hruby VJ, Cai M, Nyberg J, Muthu D · Expert Opin Drug Discov 2011 · PubMed · DOI · Free full text

    Uses MT-II as the reference agonist, reporting binding IC50 of about 0.2, 1.25, 1.07 and 7.47 nM at human MC1R, MC3R, MC4R and MC5R with full cAMP efficacy. Values come from one laboratory's assay system.

  4. 04
    Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

    Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD · Nature 1997 · DOI

    Intracerebroventricular MT-II inhibited feeding in four mouse models of hyperphagia, and SHU9119 blocked the effect, establishing tonic melanocortin inhibition of feeding. Acute central dosing in mice only.

  5. 05
    Chronic application of MTII in a rat model of obesity results in sustained weight loss

    Hamilton BS, Doods HN · Obes Res 2002 · DOI

    Continuous MT-II reduced day-14 body weight by 22.5 g in chow-fed and 30.7 g in diet-obese female rats against 1.6 and 7.1 g on saline, with raised oxygen consumption. Female ex-breeder rats of one strain; food intake recovered over time.

  6. 06
    Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity

    Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS · Diabetes 2002 · DOI

    In diet-obese mice MT-II cut feeding for 4 days before intake returned to control, weight plateaued below controls, and leptin and insulin fell. Shows tachyphylaxis of the feeding effect; short study duration.

  7. 07
    Intermittent MTII application evokes repeated anorexia and robust fat and weight loss

    Zhang Y, Collazo R, Gao Y, Li G, Scarpace PJ · Peptides 2010 · PubMed · DOI · Free full text

    Central MT-II infusion cut food intake by about 30% for under 5 days, yet adiposity fell about 80% by day 30 and hypothalamic MC4R expression fell 25%. Small rat study with central delivery only.

  8. 08
    Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors

    Wessells H, Hruby VJ, Hackett J, Han G, Balse-Srinivasan P, Vanderah TW · Neuroscience 2003 · PubMed · DOI

    MT-II produced dose-dependent erections in awake rats by brain, spinal and intravenous routes, most effectively at the lumbosacral cord, with no local penile action. Rat model; site-specific delivery.

  9. 09
    Vyleesi (bremelanotide injection): US prescribing information

    FDA-approved labeling · FDA label, initial US approval 2019 · Free full text

    Describes bremelanotide as Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys-OH), MW 1025.2, a melanocortin agonist with MC1R and MC4R most relevant. Applies to bremelanotide, not MT-II.

  10. 10
    FDA approves SCENESSE (afamelanotide) for erythropoietic protoporphyria

    Clinuvel Pharmaceuticals · Press release, October 2019

    Announces FDA approval of the afamelanotide (melanotan I) 16 mg implant on October 8, 2019. A company press release; regulatory status only.

  11. 11
    FDA warns consumers against using Melanotan II (consumer update, archived)

    US Food and Drug Administration · FDA, September 2007

    FDA described Melanotan II as an unapproved product and issued a warning letter to a website seller. Archived 2007 page; regulatory history only.

  12. 12
    FDA considers adding a dozen peptides to its bulk drug compounding list

    Regulatory Affairs Professionals Society · RAPS, April 2026

    Reports FDA's April 2026 plan to move twelve peptides, including Melanotan II, out of Category 2 and to have the advisory committee review Melanotan II before the end of February 2027. News report of a process still under way.

Frequently asked questions

How is Melanotan II (MT2) packaged?

Melanotan II (MT2) is supplied in the product format and quantity shown for the selected variant. Please inspect the sealed package when it arrives and contact support promptly if the package or labeling appears damaged.

How is Melanotan II (MT2) shipped?

Orders are shipped within the United States via USPS. Transit times are typically 3–7 business days, depending on destination and carrier conditions. Tracking information is provided when available.

How should Melanotan II (MT2) be stored?

Storage requirements are product-specific. Keep Melanotan II (MT2) in its original labeled container and follow the product documentation or manufacturer instructions supplied with the order. Contact support if the applicable storage guidance is not available.

What is the refund policy for Melanotan II (MT2)?

Due to the nature of research materials, NextGenPeps orders are final and are not eligible for refunds, returns, or exchanges. Review the shipping and reship policies before ordering.

Is Melanotan II (MT2) intended for human use?

No. NextGenPeps materials are supplied strictly for laboratory research and development use and are not intended for human or animal consumption, clinical use, diagnostic use, cosmetic use, or dietary use.

Customer reviews

5.0out of 5 · 3 reviews

Great communication

Support was very helpful in sorting out payment issues, very polite and fast responses

Tony V.

Excellent Batch Consistency

Performed well during evaluation. Physical appearance was crystal clear and had great quality control over multiple batches.

Emily G.

Consistent

Exceeded expectations with no signs of degradation, highly recommended

Eric U.

Common research questions

What is MT2 peptide?

MT2 is Melanotan II (also written MT-II or Melanotan 2), a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. It was designed in the late 1980s, and the cyclic lactam bridge, norleucine and D-phenylalanine make it more potent and longer-acting than the natural hormone in skin bioassays. In research it is used as a broad agonist of the melanocortin receptors. It is not an FDA-approved drug.

What does MT2 do in research models?

MT2 activates four melanocortin receptors (MC1R, MC3R, MC4R and MC5R). In pigment cells that stimulates melanin production; in rodents it reduced food intake in several obesity models and lowered body weight and fat; and in rats it produced erections through brain and spinal pathways. Because it is non-selective, it is often used as the reference agonist against which more selective compounds are measured.

What is the difference between MT2 and MT1?

Melanotan I (afamelanotide) is a linear 13-residue alpha-MSH analog studied mainly for pigmentation, and it is FDA-approved as an implant for erythropoietic protoporphyria. Melanotan II is a shorter, cyclic 7-residue analog that binds MC1R, MC3R, MC4R and MC5R tightly, so its animal effects extend to feeding and erectile responses. MT2 is not approved for any use.

Is Melanotan 2 legal or FDA approved?

Melanotan II is not FDA-approved, and in 2007 the FDA warned against it as an unapproved product. In April 2026 the FDA said it would remove Melanotan II from Category 2 of its compounding safety-concern list and have its Pharmacy Compounding Advisory Committee review it before the end of February 2027; that review does not make it an approved drug. NextGenPeps supplies it for laboratory research only.

Is MT2 the same as PT-141?

No. PT-141 (bremelanotide) shares MT2's ring and sequence but carries a free carboxylic acid at the C-terminus where MT2 has an amide, a mass difference of about 1 Da. Bremelanotide was approved by the FDA in 2019 as Vyleesi; MT2 was not. Results from one compound should not be assumed for the other.

Why does MT2 reduce food intake in animal studies?

MT2 activates MC3R and MC4R on hypothalamic neurons, the pathway that sits downstream of leptin and normally signals satiety. In mice the antagonist SHU9119 completely blocked its effect on feeding. The reduction fades within about 5 days of continuous exposure in rats and mice, although weight and fat stay lower, which studies attribute partly to higher energy expenditure.

Frequently Researched with

BPC-157

✓ 99.748% purity

BPC-157

$46.00$37.00

GHK-Cu

✓ 99.73% purity

GHK-Cu

$74.00$59.00

You have an unfinished subscription checkout

Continue your saved checkout, or replace its item with . Your saved selection and existing subscriptions will stay unchanged.

Continue saved checkout
NextGenPeps

Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.

Customer Service: +1 (971) 300-1435

Get 10% Off Your First Order

Sign up now and receive a 10% discount code valid on your next purchase!

Nextgenpeps LLC

The statements made within this website have not been evaluated by the US Food and Drug Administration. The materials offered by this company are not intended to diagnose, treat, cure, or prevent any disease. All research materials on this site are for laboratory research and development use only, and are not intended for human use.

NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

Privacy PolicyTerms & ConditionsAffiliate Program

501 W Broadway Ste A, San Diego, CA 92101

© 2026 NextGenPeps. All rights reserved.

Visa
American Express
Mastercard
PayPal
Discover
Apple Pay